Despite some differences, the anti-proliferative and anti-migratory effects of its elimination are conserved between cancer cells suggesting that PRDX6 could be considered a key factor in different cell lines, in which its abolition would be a good therapeutic strategy. This evidence concerns the gene PRDX6 and cancer.